PHILADELPHIA (August 2, 2024) — Fox Chase Cancer Center is pleased to announce the hiring of Aitziber Buque Martinez, PhD, as an Assistant Professor in the Cancer Signaling and Microenvironment Research Program.
Prior to joining Fox Chase, Martinez was an instructor of cell biology in the Department of Radiation Oncology at the Weill Cornell Medical College in New York.
“We are very excited to have Dr. Martinez join the Fox Chase and Temple family. We look forward to her adding her considerable expertise on questioning how the immune system is altered during tumor development, as well as under the effect of various metabolic disorders, to our thriving research programs,” said Edna “Eti” Cukierman, PhD, Co-Leader of the Cancer Signaling and Microenvironment Research Program and Co-Director of The Marvin and Concetta Greenberg Pancreatic Cancer Institute.
Martinez received her undergraduate degree in biochemistry from the University of the Basque Country in Leioa, Spain. She also earned a master’s degree in bioinformatics and computational biology from The Complutense University of Madrid, as well as a master’s in cellular biology and neoplastic diseases from the University of the Basque Country. Martinez earned her doctoral degree in biomedicine at the Biocruces Research Institute – University of the Basque Country.
She completed a postdoctoral fellowship at the Gustave Roussy Comprehensive Cancer Center in Paris, where she studied in the Apoptosis, Cancer, and Immunity Laboratory. She then went on to become a postdoctoral associate in the Department of Radiation Oncology at the Weill Cornell Medical College, before becoming an instructor of cell biology there.
She has published more than 60 articles in peer-reviewed journals and has served as co-editor of Methods in Cell Biology.
Martinez is currently a member of the Society for Immunotherapy of Cancer (SITC), the Early Career Scientist Committee at SITC, the Spanish Scientist in USA Society, the Spanish Society for Biochemistry and Molecular Biology, and the American Association for Cancer Research.